Charles Theuer
Chief Executive Officer bij TRACON PHARMACEUTICALS, INC.
Vermogen: 1 M $ op 31-03-2024
Profiel
Charles P.
Theuer is currently the President, Chief Executive Officer & Director at TRACON Pharmaceuticals, Inc. He is also an Independent Director at 4D Molecular Therapeutics, Inc. and Oncternal Therapeutics, Inc. Previously, he worked as the Director-Clinical Oncology at Pfizer Inc. from 2003 to 2004 and as the Chief Medical Officer & VP-Clinical Development at TargeGen, Inc. from 2004 to 2006.
He also served as an Assistant Professor-Surgical Oncology at the University of California, Irvine.
Additionally, he was a Principal at the National Cancer Institute from 1991 to 1993.
Dr. Theuer obtained his undergraduate degree from the Massachusetts Institute of Technology in 1985.
He earned his doctorate degrees from the University of California, Irvine in 2002 and the University of California, San Francisco in 1989.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 23-05-2023 | 32 351 ( 0.06% ) | 1 M $ | 31-03-2024 | |
| 12-03-2024 | 406 417 ( 0.89% ) | 174 759 $ | 31-03-2024 | |
| 28-06-2023 | 838 ( 0.03% ) | 7 542 $ | 31-03-2024 |
Actieve functies van Charles Theuer
| Bedrijven | Functie | Begin |
|---|---|---|
| TRACON PHARMACEUTICALS, INC. | Chief Executive Officer | 02-08-2006 |
| 4D MOLECULAR THERAPEUTICS, INC. | Director/Board Member | 01-01-2016 |
| ONCTERNAL THERAPEUTICS, INC. | Director/Board Member | 01-05-2018 |
Eerdere bekende functies van Charles Theuer
| Bedrijven | Functie | Einde |
|---|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Chief Tech/Sci/R&D Officer | 01-01-2006 |
| PFIZER, INC. | Corporate Officer/Principal | 01-01-2004 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | 01-01-1993 |
| University of California, Irvine | Corporate Officer/Principal | - |
Opleiding van Charles Theuer
| Massachusetts Institute of Technology | Undergraduate Degree |
| University of California, Irvine | Doctorate Degree |
| The University of California, San Francisco | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| PFIZER, INC. | Health Technology |
| TRACON PHARMACEUTICALS, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| ONCTERNAL THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
TargeGen, Inc.
TargeGen, Inc. Pharmaceuticals: MajorHealth Technology TargeGen, Inc. manufactures vascular biopharmaceutical products. The company was founded by David A. Cheresh and Peter G. Ulrich in 2001 and is headquartered in San Diego, CA. | Health Technology |
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
